SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-24-001109
Filing Date
2024-07-25
Accepted
2024-07-25 16:05:54
Documents
78
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K adag-20240725x6k.htm   iXBRL 6-K 135174
2 EX-99.1 adag-20240725xex99d1.htm EX-99.1 178537
3 EX-99.2 adag-20240725xex99d2.htm   iXBRL EX-99.2 1063864
4 GRAPHIC adag-20240725xex99d1002.jpg GRAPHIC 4540
  Complete submission text file 0001410578-24-001109.txt   6862330

Data Files

Seq Description Document Type Size
5 EX-101.SCH adag-20240725.xsd EX-101.SCH 57185
6 EX-101.CAL adag-20240725_cal.xml EX-101.CAL 56935
7 EX-101.DEF adag-20240725_def.xml EX-101.DEF 130715
8 EX-101.LAB adag-20240725_lab.xml EX-101.LAB 468900
9 EX-101.PRE adag-20240725_pre.xml EX-101.PRE 324200
81 EXTRACTED XBRL INSTANCE DOCUMENT adag-20240725x6k_htm.xml XML 1252894
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 241142065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)